Show simple item record

dc.contributor.authorHarris, E.
dc.contributor.authorMusk, A.
dc.contributor.authorde Klerk, N.
dc.contributor.authorReid, Alison
dc.contributor.authorFranklin, P.
dc.contributor.authorBrims, Fraser
dc.date.accessioned2019-02-19T04:16:05Z
dc.date.available2019-02-19T04:16:05Z
dc.date.created2019-02-19T03:58:12Z
dc.date.issued2019
dc.identifier.citationHarris, E. and Musk, A. and de Klerk, N. and Reid, A. and Franklin, P. and Brims, F. 2019. Diagnosis of asbestos-related lung diseases. Expert Review of Respiratory Medicine. 13 (3): pp. 241-249.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/74194
dc.identifier.doi10.1080/17476348.2019.1568875
dc.description.abstract

Introduction: The diagnosis of lung disease in asbestos-exposed individuals is a process that not only requires a detailed occupational and tobacco smoking history, but the correlation with physical signs, appropriate imaging, detailed lung function assessment and histology/cytology when required. Worldwide, the total quantity of asbestos mined is static, having decreased dramatically in developed countries but increased in countries where there is no restriction on mining: for example, Russia, China, Brazil, and Kazakhstan. The predominant diagnostic challenge in most cases of possible asbestos-related disease is the significant interval between exposure and development of the disease. Also challenging is the estimation of an individual's risk of disease, not least because asbestos-induced malignancy can be rapidly fatal, and, in the case of lung cancer, early detection can lead to treatment with curative intent. Areas covered: Discussion of quantitative asbestos exposure estimation and risk assessment, selection of the most appropriate imaging modality and frequency of imaging. Expert commentary: Consideration of the future for asbestos-related lung disease includes screening those at highest risk particularly in relation to ongoing mining operations and the management of in-situ asbestos. In the future, screening programs designed with estimation of risk of malignancy, based on quantitative estimates of asbestos exposure, and smoking history are indicated.

dc.titleDiagnosis of asbestos-related lung diseases
dc.typeJournal Article
dcterms.source.startPage241
dcterms.source.endPage249
dcterms.source.issn1747-6356
dcterms.source.titleExpert Review of Respiratory Medicine
curtin.departmentSchool of Public Health
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record